Aurobindo Pharma receives USFDA approval for metronidazole

Aurobindo Pharma has received USFDA approval to market Metronidazole tablets in USA. The company has received final approval from the US Food and Drug Administration (USFDA) to manufacture and market Metronidazole tablets in strengths of 250 mg and 500 mg. The product has estimated market size of $ 58 million per annum.

Company Profile : Aurobindo Pharma Ltd

Be the first to comment

Leave a Reply

Your email address will not be published.


*